GLP-1 receptor agonists are not just making waves in weight management and diabetes care—they’re showing potential in addressing various forms of addiction. By modulating dopamine pathways in the brain, these medications could help reduce cravings and compulsive behaviours across a spectrum of addictions.
Current research and potential applications include:
These developments point to a broader therapeutic role for GLP-1s, offering hope for tackling addiction alongside obesity.
As a medical weight loss clinician and a medical weight loss training company owner it’s good to see that research is helping us understand the mechanisms of action of these drugs further.
However, coming up to Christmas, will this mean that some people will be getting less presents this year?
As diaries fill with flights, train journeys and overnight stays, it’s common for patients on weekly GLP-1 therapy to worry that travel will break their
Every year as the festive season approaches, weight‑management clinics see the same pattern: routines loosen, social calendars fill, food environment cues multiply, and large meals
Obesity is one of the UK’s most urgent health challenges. Around two-thirds of adults in England are overweight or obese (NHS Digital) — and the
